Modulation of inflammation and immunity by dietary conjugated linoleic acid

European Journal of Pharmacology

Volumn 785, Issue , 2016, Pages 87-95

  Viladomiu, Monica ^a   Hontecillas, Raquel ^a   Bassaganya Riera, Josep ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Asthma; Conjugated linoleic acid; Diabetes; Inflammation; Inflammatory Bowel Disease; Obesity

Indexed keywords

CONJUGATED LINOLEIC ACID; CYTOKINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; COLORECTAL CANCER; DIET SUPPLEMENTATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; ISOMER; MOLECULAR DOCKING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE; ANIMAL; CHEMISTRY; DIETARY SUPPLEMENT; DRUG EFFECTS; IMMUNITY; ISOMERISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DIETARY SUPPLEMENTS; HUMANS; IMMUNITY; INFLAMMATION; ISOMERISM; LINOLEIC ACIDS, CONJUGATED;

EID: 84929915689     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.03.095     Document Type: Article

References (149)

1. Albers, R., van der Wielen, R.P., et al. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur. J. Clin. Nutr. 57 (2003), 595–603.
2. Bassaganya-Riera, J., Hontecillas-Magarzo, R., et al. Effects of dietary conjugated linoleic acid in nursery pigs of dirty and clean environments on growth, empty body composition, and immune competence. J. Anim. Sci. 79 (2001), 714–721.
3. Bassaganya-Riera, J., Hontecillas, R., CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin. Nutr. 25 (2006), 454–465.
4. Bassaganya-Riera, J., Hontecillas, R., Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 13 (2010), 569–573.
5. Bassaganya-Riera, J., Hontecillas, R., et al. Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Clin. Nutr. 21 (2002), 451–459.
6. Bassaganya-Riera, J., Hontecillas, R., et al. Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease. Clin. Nutr. 31 (2012), 721–727.
7. Bassaganya-Riera, J., Hontecillas, R., et al. Dietary conjugated linoleic acid modulates phenotype and effector functions of porcine CD8(+) lymphocytes. J. Nutr. 131 (2001), 2370–2377.
8. Bassaganya-Riera, J., Pogranichniy, R.M., et al. Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression. J. Nutr. 133 (2003), 3204–3214.
9. Bassaganya-Riera, J., Reynolds, K., et al. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127 (2004), 777–791.
10. Bassaganya-Riera, J., Viladomiu, M., et al. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR gamma to suppress colitis. PloS One, 7, 2012, e31238.
11. Bassaganya-Riera, J., Viladomiu, M., et al. Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PloS one, 7, 2012, e34676.
12. Belury, M.A., Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu. Rev. Nutr. 22 (2002), 505–531.
13. Belury, M.A., Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J. Nutr. 132 (2002), 2995–2998.
14. Belury, M.A., C.S., M., Lub, M., Shib, L., Leesnitzerc, L.M., Blanchardc, S.G., Conjugated linoleic acid is an activator and ligand for peroxisome proliferator-activated receptor-gamma (PPARγ). Nutr. Res., 2002, 817–824.
15. Beuther, D.A., Sutherland, E.R., Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am. J. Respir. Crit. Care Med. 175 (2007), 661–666.
16. Bhattacharya, A., Banu, J., et al. Biological effects of conjugated linoleic acids in health and disease. J. Nutr. Biochem. 17 (2006), 789–810.
17. Bibiloni, R., Fedorak, R.N., et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100 (2005), 1539–1546.
18. Bruun, J.M., Lihn, A.S., et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metabol. 90 (2005), 2282–2289.
19. Camilleri, M., GI clinical research 2002–2003: the year in review. Clin. Gastroenterol. Hepatol.: Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 1 (2003), 415–420.
20. Chin SF, L.W., Storkson, J.M., Ha, J.M., Pariza, M.W., Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J. Food Compos. Anal., 1992, 185–197.
21. Cook, M.E., Miller, C.C., et al. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poult. Sci. 72 (1993), 1301–1305.
22. Corl, B.A., Barbano, D.M., et al. cis-9, trans-11 CLA derived endogenously from trans-11 18:1 reduces cancer risk in rats. J. Nutr. 133 (2003), 2893–2900.
23. Corl, B.A., Baumgard, L.H., et al. The role of Delta(9)-desaturase in the production of cis-9, trans-11 CLA. J. Nutr. Biochem. 12 (2001), 622–630.
24. Couper, K.N., Blount, D.G., et al. IL-10: the master regulator of immunity to infection. J. Immunol. 180 (2008), 5771–5777.
25. Dandona, P., Aljada, A., et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005), 1448–1454.
26. de Cassia, da Silveira, Andrade, E.S.R., L.N., et al. A review on anti-inflammatory activity of phenylpropanoids found in essential oils. Molecules 19 (2014), 1459–1480.
27. de Lany, J.P., Blohm, F., et al. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am. J. Physiol. 276 (1999), R1172–R1179.
28. Dhiman, T.R., Nam, S.H., et al. Factors affecting conjugated linoleic acid content in milk and meat. Crit. Rev. Food Sci. Nutr. 45 (2005), 463–482.
29. Dilzer, A., Park, Y., Implication of conjugated linoleic acid (CLA) in human health. Crit. Rev. Food Sci. Nutr. 52 (2012), 488–513.
30. Dubuquoy, L., Rousseaux, C., et al. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 55 (2006), 1341–1349.
31. Eaden, J.A., Abrams, K.R., et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001), 526–535.
32. Evans, N.P., Misyak, S.A., et al. Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma. J. Nutr. 140 (2010), 515–521.
33. Ewaschuk, J.B., Walker, J.W., et al. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J. Nutr. 136 (2006), 1483–1487.
34. Ferrero-Miliani, L., Nielsen, O.H., et al. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol. 147 (2007), 227–235.
35. Gorissen, L., Raes, K., et al. Production of conjugated linoleic acid and conjugated linolenic acid isomers by Bifidobacterium species. Appl. Microbiol. Biotechnol. 87 (2010), 2257–2266.
36. Griinari, J.M., Corl, B.A., et al. Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by Delta(9)-desaturase. J. Nutr. 130 (2000), 2285–2291.
37. Ha, Y.L., Grimm, N.K., et al. Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 8 (1987), 1881–1887.
38. Halade, G.V., Rahman, M.M., et al. Differential effects of conjugated linoleic acid isomers in insulin-resistant female C57Bl/6J mice. J. Nutr. Biochem. 21 (2010), 332–337.
39. Hargrave, K.M., Li, C., et al. Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic Acid in mice. Obes. Res. 10 (2002), 1284–1290.
40. Harizi, H., Corcuff, J.B., et al. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends in molecular medicine 14 (2008), 461–469.
41. Hjellvik, V., Tverdal, A., et al. Body mass index as predictor for asthma: a cohort study of 118,723 males and females. Eur. Respir. J. 35 (2010), 1235–1242.
42. Hontecillas, R., Bassaganya-Riera, J., Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis. J. Immunol. 178 (2007), 2940–2949.
43. Hontecillas, R., Wannemeulher, M.J., et al. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J. Nutr. 132 (2002), 2019–2027.
44. Hotamisligil, G.S., Shargill, N.S., et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
45. House, R.L., Cassady, J.P., et al. Conjugated linoleic acid evokes de-lipidation through the regulation of genes controlling lipid metabolism in adipose and liver tissue. Obes. Rev.: Off. J. Int. Assoc. Stud. Obes. 6 (2005), 247–258.
46. Jaudszus, A., Foerster, M., et al. Cis-9,trans-11-CLA exerts anti-inflammatory effects in human bronchial epithelial cells and eosinophils: comparison to trans-10,cis-12-CLA and to linoleic acid. Biochim. Biophys. Acta 1737 (2005), 111–118.
47. Jaudszus, A., Krokowski, M., et al. Cis-9,trans-11-conjugated linoleic acid inhibits allergic sensitization and airway inflammation via a PPARgamma-related mechanism in mice. J. Nutr. 138 (2008), 1336–1342.
48. Jemal, A., Siegel, R., et al. Cancer statistics, 2008. CA: Cancer J. Clin. 58 (2008), 71–96.
49. Jiang, C., Ting, A.T., et al. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998), 82–86.
50. Kay, J.K., Mackle, T.R., et al. Endogenous synthesis of cis-9, trans-11 conjugated linoleic acid in dairy cows fed fresh pasture. J. Dairy Sci. 87 (2004), 369–378.
51. Kelley, D.S., Warren, J.M., et al. Similar effects of c9,t11-CLA and t10,c12-CLA on immune cell functions in mice. Lipids 37 (2002), 725–728.
52. Kelley, N.S., Hubbard, N.E., et al. Conjugated linoleic acid isomers and cancer. J. Nutr. 137 (2007), 2599–2607.
53. Kennedy, A., Chung, S., et al. Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. J. Nutr. 138 (2008), 455–461.
54. Kennedy, A., Martinez, K., et al. Antiobesity mechanisms of action of conjugated linoleic acid. J. Nutr. Biochem. 21 (2010), 171–179.
55. Kepler, C.R., Tucker, W.P., et al. Biohydrogenation of unsaturated fatty acids. V. Stereospecificity of proton addition and mechanism of action of linoleic acid delta 12-cis, delta 11-trans-isomerase from Butyrivibrio fibrisolvens. J. Biol. Chem. 246 (1971), 2765–2771.
56. Khan, S.A., Vanden Heuvel, J.P., Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J. Nutr. Biochem. 14 (2003), 554–567.
57. Kim, D.I., Kim, K.H., et al. Trans-10, cis-12-conjugated linoleic acid modulates NF-kappaB activation and TNF-alpha production in porcine peripheral blood mononuclear cells via a PPARgamma-dependent pathway. Br. J. Nutr. 105 (2011), 1329–1336.
58. Kim, S.R., Lee, K.S., et al. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma. Mol. Pharmacol. 68 (2005), 1568–1575.
59. Koeberle, A., Werz, O., Multi-target approach for natural products in inflammation. Drug Discov. Today, 2014.
60. Krey, G., Braissant, O., et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 (1997), 779–791.
61. Kritchevsky, D., Antimutagenic and some other effects of conjugated linoleic acid. Br. J. Nutr. 83 (2000), 459–465.
62. Kuhnt, K., Kraft, J., et al. Trans-11-18: 1 is effectively Delta9-desaturated compared with trans-12-18: 1 in humans. Br. J. Nutr. 95 (2006), 752–761.
63. Lakatos, P.L., Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J. Gastroenterol. 12 (2006), 6102–6108.
64. Lambert, E.V., Goedecke, J.H., et al. Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. Br. J. Nutr. 97 (2007), 1001–1011.
65. Lee, K.N., Kritchevsky, D., et al. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108 (1994), 19–25.
66. Lee, K.S., Park, S.J., et al. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 19 (2005), 1033–1035.
67. Lee, K.S., Park, S.J., et al. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma. J. Immunol. 177 (2006), 5248–5257.
68. Lee, S.Y., Kang, E.J., et al. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291 (2006), L84–L90.
69. Lewis, J.D., Lichtenstein, G.R., et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology 134 (2008), 688–695.
70. Loscher, C.E., Draper, E., et al. Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J. Immunol. 175 (2005), 4990–4998.
71. Maconi, G., Colombo, E., et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig. Liver Dis.: Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Stud. Liver 37 (2005), 418–423.
72. Macredmond, R., Dorscheid, D.R., Conjugated linoleic acid (CLA): is it time to supplement asthma therapy?. Pulm. pharmacol. Ther. 24 (2011), 540–548.
73. MacRedmond, R., Singhera, G., et al. Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics. Clin. Exp. Allergy: J. Br. Soc. Allergy Clin. Immunol. 40 (2010), 1071–1078.
74. Madsen, K., Cornish, A., et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121 (2001), 580–591.
75. Marcy, T.R., Britton, M.L., et al. Second-generation thiazolidinediones and hepatotoxicity. Ann. Pharmacother. 38 (2004), 1419–1423.
76. McGuirk, P., McCann, C., et al. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195 (2002), 221–231.
77. McNeel, R.L., Smith, E.O., et al. Isomers of conjugated linoleic acid modulate human preadipocyte differentiation. In vitro Cell. Dev. Biol. Anim. 39 (2003), 375–382.
78. Meadus, W.J., MacInnis, R., et al. Prolonged dietary treatment with conjugated linoleic acid stimulates porcine muscle peroxisome proliferator activated receptor gamma and glutamine-fructose aminotransferase gene expression in vivo. J. Mol. Endocrinol. 28 (2002), 79–86.
79. Medina, E.A., Horn, W.F., et al. Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 35 (2000), 783–788.
80. Medzhitov, R., Origin and physiological roles of inflammation. Nature 454 (2008), 428–435.
81. Mendis, S., Cruz-Hernandez, C., et al. Fatty acid profile of Canadian dairy products with special attention to the trans-octadecenoic acid and conjugated linoleic acid isomers. J. AOAC Int. 91 (2008), 811–819.
82. Miller, C.C., Park, Y., et al. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem. Biophys. Res. Commun. 198 (1994), 1107–1112.
83. Miller, J.R., Siripurkpong, P., et al. The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPARgamma-dependent and PPARgamma-independent mechanisms. J. Lipid Res. 49 (2008), 550–562.
84. Mills, K.H., McGuirk, P., Antigen-specific regulatory T cells–their induction and role in infection. Semin. Immunol. 16 (2004), 107–117.
85. Miner, J.L., Cederberg, C.A., et al. Conjugated linoleic acid (CLA), body fat, and apoptosis. Obes. Res. 9 (2001), 129–134.
86. Mitchell, P.L., McLeod, R.S., Conjugated linoleic acid and atherosclerosis: studies in animal models. Biochem. Cell Biol.=Biochim. Biol. Cell. 86 (2008), 293–301.
87. Moloney, F., Toomey, S., et al. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 56 (2007), 574–582.
88. Moon, H.S., Biological effects of conjugated linoleic acid on obesity-related cancers. Chem.-Biol. Interact. 224C (2014), 189–195.
89. Moya-Camarena, S.Y., Van den Heuvel, J.P., et al. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim. Biophys. Acta 1436 (1999), 331–342.
90. Moya-Camarena, S.Y., Vanden Heuvel, J.P., et al. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res. 40 (1999), 1426–1433.
91. Munkholm, P., Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18:Suppl 2 (2003), S1–S5.
92. Mushtaq, S., Heather Mangiapane, E., et al. Estimation of cis-9, trans-11 conjugated linoleic acid content in UK foods and assessment of dietary intake in a cohort of healthy adults. Br. J. Nutr. 103 (2010), 1366–1374.
93. Nesto, R.W., Bell, D., et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation 108 (2003), 2941–2948.
94. O'Shea, M., Bassaganya-Riera, J., et al. Immunomodulatory properties of conjugated linoleic acid. Am. J. Clin. Nutr. 79 (2004), 1199S–1206S.
95. Ochoa, J.J., Farquharson, A.J., et al. Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 25 (2004), 1185–1191.
96. Oleszczuk, J., Oleszczuk, L., et al. Biological effects of conjugated linoleic acids supplementation. Pol. J. Vet. Sci. 15 (2012), 403–408.
97. Ostrowska, E., Muralitharan, M., et al. Dietary conjugated linoleic acids increase lean tissue and decrease fat deposition in growing pigs. J. Nutr. 129 (1999), 2037–2042.
98. Park, Y., Albright, K.J., et al. Effect of conjugated linoleic acid on body composition in mice. Lipids 32 (1997), 853–858.
99. Park, Y., Storkson, J.M., et al. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 34 (1999), 235–241.
100. Parodi, P.W., Cows’ milk fat components as potential anticarcinogenic agents. J. Nutr. 127 (1997), 1055–1060.
101. Perdomo, M.C., Santos, J.E., et al. Trans-10, cis-12 conjugated linoleic acid and the PPAR-gamma agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-alpha production by bovine immune cells. Domest. Anim. Endocrinol. 41 (2011), 118–125.
102. Peterson, K.M., O'Shea, M., et al. Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness. Antiviral Ther. 14 (2009), 33–43.
103. Plourde, M., Jew, S., et al. Conjugated linoleic acids: why the discrepancy between animal and human studies?. Nutr. Rev. 66 (2008), 415–421.
104. Punchard, N.A., Whelan, C.J., et al. J. Inflamm. (Lond.), 1, 2004, 1.
105. Richards, D.B., Bareille, P., et al. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial. Respir. Med. 104 (2010), 668–674.
106. Ringseis, R., Muller, A., et al. CLA isomers inhibit TNFalpha-induced eicosanoid release from human vascular smooth muscle cells via a PPARgamma ligand-like action. Biochim. Biophys. Acta 1760 (2006), 290–300.
107. Riserus, U., Berglund, L., et al. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Stud. Obes. 25 (2001), 1129–1135.
108. Riserus, U., Vessby, B., et al. Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am. J. Clin. Nutr. 80 (2004), 279–283.
109. Ritzenthaler, K.L., McGuire, M.K., et al. Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluated by food duplicate methodology. J. Nutr. 131 (2001), 1548–1554.
110. Ryder, J.W., Portocarrero, C.P., et al. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 50 (2001), 1149–1157.
111. Santora, J.E., Palmquist, D.L., et al. Trans-vaccenic acid is desaturated to conjugated linoleic acid in mice. J. Nutr. 130 (2000), 208–215.
112. Scrascia, M., Forcillo, M., et al. Susceptibility to rifaximin of Vibrio cholerae strains from different geographical areas. J. Antimicrob. Chemother. 52 (2003), 303–305.
113. Sebedio, J.L., Gnaedig, S., et al. Recent advances in conjugated linoleic acid research. Curr. Opin. Clin. Nutr. Metab. Care 2 (1999), 499–506.
114. Shore, S.A., Terry, R.D., et al. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 118 (2006), 389–395.
115. Sisk, M.B., Hausman, D.B., et al. Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J. Nutr. 131 (2001), 1668–1674.
116. So, M.H., Tse, I.M., et al. Dietary fat concentration influences the effects of trans-10, cis-12 conjugated linoleic acid on temporal patterns of energy intake and hypothalamic expression of appetite-controlling genes in mice. J. Nutr. 139 (2009), 145–151.
117. Sood, A., Verhulst, S.J., et al. Association of excess weight and degree of airway responsiveness in asthmatics and non-asthmatics. J. Asthma: Off. J. Assoc. Care Asthma 43 (2006), 447–452.
118. Spears, M., Donnelly, I., et al. Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin. Pharmacol. Ther. 86 (2009), 49–53.
119. Stenius-Aarniala, B., Poussa, T., et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 320 (2000), 827–832.
120. Sugano, M., Tsujita, A., et al. Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 33 (1998), 521–527.
121. Takahashi, Y., Kushiro, M., et al. Dietary conjugated linoleic acid reduces body fat mass and affects gene expression of proteins regulating energy metabolism in mice. Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 133 (2002), 395–404.
122. Terpstra, A.H., Beynen, A.C., et al. The decrease in body fat in mice fed conjugated linoleic acid is due to increases in energy expenditure and energy loss in the excreta. J. Nutr. 132 (2002), 940–945.
123. Tholstrup, T., Raff, M., et al. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. J. Nutr. 138 (2008), 1445–1451.
124. Tontonoz, P., Nagy, L., et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93 (1998), 241–252.
125. Tsuboyama-Kasaoka, N., Takahashi, M., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49 (2000), 1534–1542.
126. Turpeinen, A.M., Ylonen, N., et al. Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy. Br. J. Nutr. 100 (2008), 112–119.
127. Urquhart, P., Parkin, S.M., et al. The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim. Biophys. Acta 1580 (2002), 150–160.
128. Vendrell, J., Broch, M., et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12 (2004), 962–971.
129. Wallace, R.J., McKain, N., et al. Isomers of conjugated linoleic acids are synthesized via different mechanisms in ruminal digesta and bacteria. J. Lipid Res. 48 (2007), 2247–2254.
130. Wang, T., Lee, H.G., Advances in research on cis-9, trans-11 conjugated linoleic acid: a major functional conjugated linoleic acid isomer. Crit. Rev. Food Sci. Nutr., 2013.
131. Wang, Y.W., Jones, P.J., Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Stud. Obes. 28 (2004), 941–955.
132. Weisberg, S.P., McCann, D., et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 112 (2003), 1796–1808.
133. Weiss, S.T., Obesity: insight into the origins of asthma. Nat. Immunol. 6 (2005), 537–539.
134. West, D.B., Delany, J.P., et al. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am. J. Physiol. 275 (1998), R667–R672.
135. Whigham, L.D., Cook, M.E., et al. Conjugated linoleic acid: implications for human health. Pharmacol. Res.: Off. J. Ital. Pharmacol. Soc. 42 (2000), 503–510.
136. Whigham, L.D., Higbee, A., et al. Decreased antigen-induced eicosanoid release in conjugated linoleic acid-fed guinea pigs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002), R1104–R1112.
137. Whigham, L.D., Watras, A.C., et al. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am. J. Clin. Nutr. 85 (2007), 1203–1211.
138. Wilson, H.M., Barker, R.N., et al. Macrophages: promising targets for the treatment of atherosclerosis. Curr. Vasc. Pharmacol. 7 (2009), 234–243.
139. Woerly, G., Honda, K., et al. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J. Exp. Med. 198 (2003), 411–421.
140. Wohlfert, E.A., Nichols, F.C., et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J. Immunol. 178 (2007), 4129–4135.
141. Xie, J., Itzkowitz, S.H., Cancer in inflammatory bowel disease. World J. Gastroenterol. 14 (2008), 378–389.
142. Xu, H.E., Lambert, M.H., et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 3 (1999), 397–403.
143. Yamasaki, M., Chujo, H., et al. Immunoglobulin and cytokine production from spleen lymphocytes is modulated in C57BL/6J mice by dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid. J. Nutr. 133 (2003), 784–788.
144. Yamasaki, M., Ikeda, A., et al. Modulation of body fat and serum leptin levels by dietary conjugated linoleic acid in Sprague-Dawley rats fed various fat-level diets. Nutrition 19 (2003), 30–35.
145. Yamasaki, M., Mansho, K., et al. Dietary effect of conjugated linoleic acid on lipid levels in white adipose tissue of Sprague-Dawley rats. Biosci. Biotechnol. Biochem. 63 (1999), 1104–1106.
146. Yang, M., Cook, M.E., Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp. Biol. Med. (Maywood) 228 (2003), 51–58.
147. Yu, Y., Correll, P.H., et al. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim. Biophys. Acta 1581 (2002), 89–99.
148. Zabala, A., Portillo, M.P., et al. Effects of cis-9,trans-11 and trans-10,cis-12 CLA isomers on liver and adipose tissue fatty acid profile in hamsters. Lipids 41 (2006), 993–1001.
149. Zambell, K.L., Keim, N.L., et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35 (2000), 777–782.